Another Bay Area biotech files plans to go public

Favicon Business Journal

A South San Francisco company tapping the brain's immune system to treat Alzheimer's disease and other neurodegenerative conditions said Monday that it wants to raise $150 million in an initial public offering. Alector Inc., which has nearly 100 employees and last year closed a $225 million deal with AbbVie Inc. (NYSE: ABBV), would trade on the NASDAQ with the trading symbol "ALEC." It is the second South San Francisco biotech company with public plans for a likely 2019 IPO, joining Harpoon Therapeutics...

Read the full article here: Business Journal


The post: «Another Bay Area biotech files plans to go public» has been published on the website Business Journal where, everyday, you can find the latest news about San Jose's area.



Get more articles about this topic

Leave a comment